New Buy Calls on PALI, LBRX, CCCC and DFTX: Targets, Cash and What the Analysts Are Betting On
Targets imply 88% to 314% upside, with cash into 2027-2030.
Already have an account? Sign in.
Targets imply 88% to 314% upside, with cash into 2027-2030.
Weltruza is the first monthly subcutaneous olanzapine for schizophrenia, with no loading dose and no post-shot clinic monitoring.
Delta’s fuel bill is set to rise about $6 billion in 2026. The airline now guides adjusted earnings of $5.10–$5.60 a share, below July’s range.
Lumentum CEO says AI optical parts are sold out through early 2029, with large supply shortfalls expected through 2028.
Be the first to know when deals break, stocks move, or biotech headlines hit.